Emergency Management of Eclamptic Seizure
Immediate Actions
- Call for emergency help
- Position patient on left side to improve blood flow
- Protect from injury (padding, remove objects)
- Maintain airway - suction if needed
- Administer oxygen 8-10 L/min by face mask
- Establish IV access
- Begin magnesium sulfate immediately
- Monitor vital signs and fetal heart rate
Magnesium Sulfate Protocol
- Loading dose: 4-6g IV over 15-20 minutes
- Maintenance: 2g/hour continuous infusion
- Recurrent seizure: 2g IV bolus over 5 minutes
- Continue: 24 hours postpartum
Understanding Eclampsia
Eclampsia represents the convulsive manifestation of preeclampsia, though seizures can occur without preceding severe features. The exact pathophysiology involves cerebral vasospasm, endothelial dysfunction, and blood-brain barrier disruption.
Key Statistics
- Incidence: 1.6-10 per 10,000 deliveries in developed countries
- Higher rates in developing countries
- Maternal mortality: 1-2% in developed countries, up to 15% in developing
- Perinatal mortality: 5-12%
- Can occur without warning signs in 20-40%
- Postpartum eclampsia: 30-50% of cases
Timing of Eclampsia
- Antepartum: 38-53% (before labor)
- Intrapartum: 18-36% (during labor)
- Postpartum: 11-44% (after delivery)
- Most within 48 hours
- Can occur up to 4 weeks postpartum
Clinical Features
Prodromal Symptoms (60-80% of cases)
- Severe headache: Persistent, frontal or occipital
- Visual disturbances:
- Blurred vision
- Scotomata (blind spots)
- Flashing lights
- Temporary blindness
- Epigastric/RUQ pain: From liver involvement
- Altered mental status: Confusion, agitation
- Nausea and vomiting
- Hyperreflexia with clonus
Seizure Characteristics
- Type: Generalized tonic-clonic (grand mal)
- Duration: Usually 60-90 seconds
- Phases:
- Facial twitching (15-20 seconds)
- Tonic phase: rigid body (15-20 seconds)
- Clonic phase: convulsions (60 seconds)
- Postictal phase: coma/confusion
- Number: Usually single, but can be multiple
Associated Features
- Hypertension: Usually severe (≥160/110)
- Proteinuria: Often significant
- Edema: Facial and peripheral
- Oliguria: <500mL/24 hours
- Pulmonary edema: 3-5% of cases
- HELLP syndrome: 10-15% association
Pathophysiology
Mechanisms of Seizures
- Cerebral vasospasm: Reduced perfusion
- Hypertensive encephalopathy: Autoregulation failure
- Endothelial dysfunction: BBB disruption
- Cerebral edema: Vasogenic and cytotoxic
- Microinfarctions and hemorrhages
- Posterior reversible encephalopathy syndrome (PRES)
Risk Factors
Major Risk Factors
- Preeclampsia with severe features
- Previous eclampsia (2-16% recurrence)
- HELLP syndrome
- Nulliparity
- Multiple gestation
- Teenage pregnancy
- Advanced maternal age (>35)
Additional Risk Factors
- Chronic hypertension
- Pregestational diabetes
- Chronic kidney disease
- Antiphospholipid syndrome
- African ancestry
- Low socioeconomic status
- Limited prenatal care
Diagnosis and Evaluation
Clinical Diagnosis
Eclampsia is diagnosed when new-onset seizures occur in pregnancy or postpartum, not attributable to other causes. Preeclampsia is usually present but not required.
Laboratory Studies
- CBC with platelets: Thrombocytopenia, hemolysis
- Liver enzymes: AST, ALT elevation
- Creatinine: Assess renal function
- LDH: Hemolysis marker
- Uric acid: Often elevated
- Coagulation studies: PT, PTT, fibrinogen
- Urinalysis: Proteinuria quantification
Imaging
- Brain imaging (MRI/CT):
- Not routine
- If focal deficits
- Atypical presentation
- Prolonged coma
- Shows PRES in 90%
- Chest X-ray: If pulmonary edema suspected
Differential Diagnosis
- Epilepsy
- Cerebrovascular accident
- Hypertensive encephalopathy
- Metabolic disorders (hypoglycemia, uremia)
- CNS infection
- Intracranial mass
- Drug toxicity
- Thrombotic thrombocytopenic purpura
Treatment
Seizure Control and Prevention
Magnesium Sulfate (First-line)
- Mechanism: Cerebral vasodilation, NMDA receptor blockade
- Loading: 4-6g IV over 15-20 minutes
- Maintenance: 2g/hour IV infusion
- Duration: 24 hours postpartum or last seizure
- Monitoring:
- Deep tendon reflexes hourly
- Respiratory rate
- Urine output
- Serum levels if toxicity suspected
- Toxicity signs: Loss of DTRs, respiratory depression
- Antidote: Calcium gluconate 1g IV
Alternative Agents (if MgSO4 contraindicated)
- Phenytoin (less effective)
- Diazepam (higher recurrence)
- Levetiracetam (emerging option)
Blood Pressure Management
- Goal: 140-160/90-110 mmHg
- First-line agents:
- Labetalol 20mg IV, then 40-80mg q10min
- Hydralazine 5-10mg IV q20min
- Nifedipine 10-20mg PO q30min
- Avoid: Sudden BP drops (placental hypoperfusion)
Delivery Planning
- Timing: After maternal stabilization
- Not immediate: Unless fetal compromise
- Mode:
- Vaginal delivery preferred if stable
- Cesarean for obstetric indications
- Continuous fetal monitoring
Supportive Care
- Foley catheter for strict I/O
- Fluid restriction: 80mL/hour
- Avoid diuretics unless pulmonary edema
- Continuous pulse oximetry
- Neurological assessments
Prevention
Primary Prevention (Preventing Preeclampsia)
- Low-dose aspirin: 81mg daily from 12-28 weeks for high-risk
- Calcium supplementation: If dietary intake <600mg/day
- Regular prenatal care: Early detection
- Risk factor modification: Weight, BP control
Secondary Prevention (Preventing Eclampsia)
- Magnesium sulfate prophylaxis:
- All women with preeclampsia with severe features
- During labor and 24 hours postpartum
- Reduces eclampsia risk by 50%
- Timely delivery: For severe preeclampsia
- Close monitoring: Symptoms, BP, labs
- Patient education: Warning signs
Recurrence Prevention
- Preconception counseling
- Early prenatal care
- Aspirin prophylaxis
- Serial BP and urine monitoring
- Growth ultrasounds
- Antenatal testing
Complications
Maternal Complications
- Neurological:
- Intracranial hemorrhage (1-2%)
- Cerebral edema
- Cortical blindness
- Status epilepticus
- Cardiopulmonary:
- Pulmonary edema
- Aspiration pneumonia
- Cardiac arrest
- Renal:
- Acute kidney injury
- Permanent renal damage
- Hepatic:
- Hepatic rupture
- Liver failure
- Hematologic:
- DIC
- Severe thrombocytopenia
Fetal/Neonatal Complications
- Placental abruption (10%)
- Preterm delivery
- IUGR
- Hypoxic-ischemic encephalopathy
- Stillbirth
- Neonatal seizures
Long-term Outcomes
Maternal Outcomes
- Most recover completely with proper treatment
- Increased lifetime cardiovascular risk
- Higher risk of:
- Chronic hypertension
- Stroke
- Venous thromboembolism
- Renal disease
- Recurrence risk: 2-16% in subsequent pregnancies
- Preeclampsia risk: 22-35% in future pregnancies
Follow-up Care
- Immediate postpartum:
- BP monitoring for 72 hours
- Continue MgSO4 x 24 hours
- Watch for late postpartum eclampsia
- 6-week visit:
- BP check
- Proteinuria resolution
- Contraception counseling
- Long-term:
- Annual BP screening
- Cardiovascular risk assessment
- Lifestyle modification counseling